Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Urokinase is required for the formation of mactinin, an alpha-actinin fragment that promotes monocyte/macrophage maturation.

Luikart S, Masri M, Wahl D, Hinkel T, Beck JM, Gyetko MR, Gupta P, Oegema T.

Biochim Biophys Acta. 2002 Aug 19;1591(1-3):99-107.

2.

Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice.

Luikart SD, Levay-Young B, Hinkel T, Shearer J, Mills C, Caldwell MD, Gyetko MR, Oegema TR.

Wound Repair Regen. 2006 Mar-Apr;14(2):123-8.

3.

Mactinin: a modulator of the monocyte response to inflammation.

Luikart SD, Krug HE, Nelson RD, Hinkel T, Majeski P, Gupta P, Mahowald ML, Oegema T.

Arthritis Res Ther. 2003;5(6):R310-6. Epub 2003 Aug 5.

4.

Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.

Luikart SD, Panoskaltsis-Mortari A, Hinkel T, Perri RT, Gupta K, Oegema TR, Gupta P.

BMC Cell Biol. 2009 Aug 28;10:60. doi: 10.1186/1471-2121-10-60.

5.

HL-60 cells degrade alpha-actinin to produce a fragment that promotes monocyte/macrophage maturation.

Masri M, Wahl D, Oegema T, Luikart S.

Exp Hematol. 1999 Feb;27(2):345-52.

PMID:
10029174
6.

A fragment of alpha-actinin promotes monocyte/macrophage maturation in vitro.

Luikart S, Wahl D, Hinkel T, Masri M, Oegema T.

Exp Hematol. 1999 Feb;27(2):337-44.

PMID:
10029173
7.
8.

Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.

Jankun J, Skrzypczak-Jankun E.

Cancer Biochem Biophys. 1999 Jul;17(1-2):109-23.

PMID:
10738907
9.

Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).

Magdolen U, Schroeck F, Creutzburg S, Schmitt M, Magdolen V.

Biol Chem. 2004 Sep;385(9):801-8.

PMID:
15493875
11.

Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.

Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M.

J Cell Physiol. 1993 Jun;155(3):595-605.

PMID:
7684044
13.

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK.

Proc Natl Acad Sci U S A. 1985 Aug;82(15):4939-43.

14.

Regulation of macrophage receptor-bound plasmin by autoproteolysis.

Falcone DJ, Borth W, McCaffrey TA, Mathew J, McAdam K.

J Biol Chem. 1994 Dec 23;269(51):32660-6.

15.
16.

Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.

Fleetwood AJ, Achuthan A, Schultz H, Nansen A, Almholt K, Usher P, Hamilton JA.

J Immunol. 2014 Apr 15;192(8):3540-7. doi: 10.4049/jimmunol.1302864. Epub 2014 Mar 10.

17.

Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.

Humphries J, Gossage JA, Modarai B, Burnand KG, Sisson TH, Murdoch C, Smith A.

J Vasc Surg. 2009 Nov;50(5):1127-34. doi: 10.1016/j.jvs.2009.06.047. Epub 2009 Aug 22.

18.

The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.

Turner PC, Baquero MT, Yuan S, Thoennes SR, Moyer RW.

Virology. 2000 Jul 5;272(2):267-80.

19.

The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation.

El Fahime E, Mills P, Lafreniere JF, Torrente Y, Tremblay JP.

Exp Cell Res. 2002 Nov 1;280(2):169-78.

PMID:
12413883

Supplemental Content

Support Center